SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sun Byun who wrote (880)11/17/1996 1:35:00 PM
From: John H. Farro   of 4342
 
Sun, thank you for clearing up the confusion and WELCOME to this Board. I think your original article was well balanced and well written. I don't think anyone can accuse you of hyping the stock.
I hope you stick around and throw in your 2 cents worth frequently, because you seem to know what your talking about and I think you have a lot to contribute.

I dug through some old articles and I found the following in the July 22 issue of Business Week:

"Dr. David Cohen of the National Cancer Institute's Laboratory of Tumor Biology and the National Institutes of Health, who worked on the research, said PN355 "has an excellent toxicity profile" and may limit drastically the ability of the (AIDS) virus to spread in the body."

Maybe you were thinking of this quote when you wrote your article.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News